A Study Comparing Four Different Rivoceranib Tablets in Healthy Participants
Clinical trial NCT05287360 · COMPLETED
Trial details
- NCT number
- NCT05287360
- Sponsor
- Elevar Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2022-03-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.